This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2005 Nov 24;353(21):2285-7.

doi: 10.1056/NEJMe058210.

Antioxidant therapy for idiopathic pulmonary fibrosis

Gary W Hunninghake

PMID: 16306527
DOI: 10.1056/NEJMe058210

Editorial

Antioxidant therapy for idiopathic pulmonary fibrosis

Gary W Hunninghake. N Engl J Med. 2005.

. 2005 Nov 24;353(21):2285-7.

doi: 10.1056/NEJMe058210.

Author

Gary W Hunninghake

PMID: 16306527
DOI: 10.1056/NEJMe058210

No abstract available

PubMed Disclaimer

Comment on

High-dose acetylcysteine in idiopathic pulmonary fibrosis.
Demedts M, Behr J, Buhl R, Costabel U, Dekhuijzen R, Jansen HM, MacNee W, Thomeer M, Wallaert B, Laurent F, Nicholson AG, Verbeken EK, Verschakelen J, Flower CD, Capron F, Petruzzelli S, De Vuyst P, van den Bosch JM, Rodriguez-Becerra E, Corvasce G, Lankhorst I, Sardina M, Montanari M; IFIGENIA Study Group. Demedts M, et al. N Engl J Med. 2005 Nov 24;353(21):2229-42. doi: 10.1056/NEJMoa042976. N Engl J Med. 2005. PMID: 16306520 Clinical Trial.

Similar articles

Antioxidant therapy in idiopathic pulmonary fibrosis: hope is kindled.
Wells AU. Wells AU. Eur Respir J. 2006 Apr;27(4):664-6. doi: 10.1183/09031936.06.00010006. Eur Respir J. 2006. PMID: 16585071 No abstract available.
High-dose acetylcysteine in idiopathic pulmonary fibrosis.
Demedts M, Behr J, Buhl R, Costabel U, Dekhuijzen R, Jansen HM, MacNee W, Thomeer M, Wallaert B, Laurent F, Nicholson AG, Verbeken EK, Verschakelen J, Flower CD, Capron F, Petruzzelli S, De Vuyst P, van den Bosch JM, Rodriguez-Becerra E, Corvasce G, Lankhorst I, Sardina M, Montanari M; IFIGENIA Study Group. Demedts M, et al. N Engl J Med. 2005 Nov 24;353(21):2229-42. doi: 10.1056/NEJMoa042976. N Engl J Med. 2005. PMID: 16306520 Clinical Trial.
[Treatment of idiopathic pulmonary fibrosis].
Dury S. Dury S. Rev Mal Respir. 2006 Apr;23(2 Pt 2):5S87-5S91. Rev Mal Respir. 2006. PMID: 16788517 French. No abstract available.
Current perspectives on the treatment of idiopathic pulmonary fibrosis.
Walter N, Collard HR, King TE Jr. Walter N, et al. Proc Am Thorac Soc. 2006 Jun;3(4):330-8. doi: 10.1513/pats.200602-016TK. Proc Am Thorac Soc. 2006. PMID: 16738197 Review.
Therapeutic management of idiopathic pulmonary fibrosis: an evidence-based approach.
Nathan SD. Nathan SD. Clin Chest Med. 2006 Mar;27(1 Suppl 1):S27-35, vi. doi: 10.1016/j.ccm.2005.08.004. Clin Chest Med. 2006. PMID: 16545630 Review.

See all similar articles

Cited by

Peroxiredoxin II expression and its association with oxidative stress and cell proliferation in human idiopathic pulmonary fibrosis.
Vuorinen K, Ohlmeier S, Leppäranta O, Salmenkivi K, Myllärniemi M, Kinnula VL. Vuorinen K, et al. J Histochem Cytochem. 2008 Oct;56(10):951-9. doi: 10.1369/jhc.2008.951806. Epub 2008 Jul 7. J Histochem Cytochem. 2008. PMID: 18606608 Free PMC article.
An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management.
Raghu G, Collard HR, Egan JJ, Martinez FJ, Behr J, Brown KK, Colby TV, Cordier JF, Flaherty KR, Lasky JA, Lynch DA, Ryu JH, Swigris JJ, Wells AU, Ancochea J, Bouros D, Carvalho C, Costabel U, Ebina M, Hansell DM, Johkoh T, Kim DS, King TE Jr, Kondoh Y, Myers J, Müller NL, Nicholson AG, Richeldi L, Selman M, Dudden RF, Griss BS, Protzko SL, Schünemann HJ; ATS/ERS/JRS/ALAT Committee on Idiopathic Pulmonary Fibrosis. Raghu G, et al. Am J Respir Crit Care Med. 2011 Mar 15;183(6):788-824. doi: 10.1164/rccm.2009-040GL. Am J Respir Crit Care Med. 2011. PMID: 21471066 Free PMC article.
New insights into the role of oxidative stress in scleroderma fibrosis.
Gabrielli A, Svegliati S, Moroncini G, Amico D. Gabrielli A, et al. Open Rheumatol J. 2012;6:87-95. doi: 10.2174/1874312901206010087. Epub 2012 Jun 15. Open Rheumatol J. 2012. PMID: 22802906 Free PMC article.
Dietary intake and incidence risk of idiopathic pulmonary fibrosis: a Mendelian randomization study.
Zhang Y, Gan Y, Zhang H. Zhang Y, et al. BMC Pulm Med. 2023 Oct 6;23(1):376. doi: 10.1186/s12890-023-02673-4. BMC Pulm Med. 2023. Retraction in: BMC Pulm Med. 2024 Mar 15;24(1):131. doi: 10.1186/s12890-024-02963-5. PMID: 37803281 Free PMC article. Retracted.
Idiopathic pulmonary fibrosis : new concepts in pathogenesis and implications for drug therapy.
Horowitz JC, Thannickal VJ. Horowitz JC, et al. Treat Respir Med. 2006;5(5):325-42. doi: 10.2165/00151829-200605050-00004. Treat Respir Med. 2006. PMID: 16928146 Free PMC article. Review.

See all "Cited by" articles

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Medical
- MedlinePlus Health Information